Association Between Number of Medications and Indicators of Potentially Inappropriate Polypharmacy: a Population-based Cohort of Older Adults in Quebec, Canada

Overview

Journal Ther Adv Drug Saf

Publisher Sage Publications

Date 2024 Dec 31

PMID 39737141

Authors

Alexandre Campeau Calfat

Justin P Turner

Marc Simard

Veronique Boiteau

Caroline Sirois

Affiliations

Soon will be listed here.

Abstract

Background: As the number of medications increases, the appropriateness of polypharmacy may become questionable due to the heightened risk of medication-related harm.

Objectives: (1) To investigate the relationship between the number of current medications used by older adults and three indicators of potentially inappropriate polypharmacy: (a) the mean number of potentially inappropriate medications (PIMs), (b) the average count of drug-drug interactions, and (c) the anticholinergic burden; (2) To characterize the population-based burden of potentially inappropriate polypharmacy by calculating the proportion of individuals with these indicators.

Design: We conducted a population-based observational study using the Quebec Integrated Chronic Disease Surveillance System.

Methods: We included all individuals over 65 years insured by the public drug plan on April 1st, 2022. For each individual, we calculated the number of current medications and the number of (a) PIMs (Beers 2019), (b) drug-drug interactions (Beers 2019), and (c) anticholinergic burden (Anticholinergic Cognitive Burden (ACB) scale). The association between the number of medications and these indicators was quantified using linear regression. Prevalence with 99% confidence intervals (CIs) was calculated.

Results: A total of 1,437,558 individuals (mean age: 75; 55% female) were included, taking an average of 4.9 medications (±4.1). For each additional medication, the mean number of PIMs, drug-drug interactions, and anticholinergic burden increased by 0.11, 0.04, and 0.17, respectively (-trend <0.0001). Nearly half the population (45.5%; 99% CI: 45.5-45.5) had a regimen containing ⩾1 PIMs, ⩾1 drug-drug interaction, or an ACB ⩾3.

Conclusion: The strong association between the increasing number of medications and reduced polypharmacy quality underscores the importance of medication count beyond therapeutic indications. With widespread medication use, many older adults face quality issues.

References

Salahudeen M, Duffull S, Nishtala P . Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015; 15:31. PMC: 4377853. DOI: 10.1186/s12877-015-0029-9. View

Mohamed M, Ramsdale E, Loh K, Arastu A, Xu H, Obrecht S . Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis. Oncologist. 2019; 25(1):e94-e108. PMC: 6964156. DOI: 10.1634/theoncologist.2019-0406. View

Lampe D, Grosser J, Gensorowsky D, Witte J, Muth C, van den Akker M . The Relationship of Continuity of Care, Polypharmacy and Medication Appropriateness: A Systematic Review of Observational Studies. Drugs Aging. 2023; 40(6):473-497. PMC: 10232587. DOI: 10.1007/s40266-023-01022-8. View

Sancar M, Kasik A, Okuyan B, Batuhan S, Izzettin F . Determination of Potential Drug-Drug Interactions Using Various Software Programs in a Community Pharmacy Setting. Turk J Pharm Sci. 2020; 16(1):14-19. PMC: 7227974. DOI: 10.4274/tjps.30932. View

Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J . Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis. BMC Geriatr. 2022; 22(1):601. PMC: 9297624. DOI: 10.1186/s12877-022-03279-x. View

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey G . What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017; 17(1):230. PMC: 5635569. DOI: 10.1186/s12877-017-0621-2. View

Robberechts A, Brumer M, Garcia-Cardenas V, Dupotey N, Steurbaut S, De Meyer G . Medication Review: What's in a Name and What Is It about?. Pharmacy (Basel). 2024; 12(1). PMC: 10892708. DOI: 10.3390/pharmacy12010039. View

Tao L, Qu X, Gao H, Zhai J, Zhang Y, Song Y . Polypharmacy and potentially inappropriate medications among elderly patients in the geriatric department at a single-center in China: A retrospective cross-sectional study. Medicine (Baltimore). 2021; 100(42):e27494. PMC: 8542109. DOI: 10.1097/MD.0000000000027494. View

. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023; 71(7):2052-2081. DOI: 10.1111/jgs.18372. View

10.

Divecha C, Tullu M, Karande S . Utilizing tables, figures, charts and graphs to enhance the readability of a research paper. J Postgrad Med. 2023; 69(3):125-131. PMC: 10394528. DOI: 10.4103/jpgm.jpgm_387_23. View

11.

Blais C, Jean S, Sirois C, Rochette L, Plante C, Larocque I . Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach. Chronic Dis Inj Can. 2014; 34(4):226-35. View

12.

Becker M, Kallewaard M, Caspers P, Schalekamp T, Stricker B . Potential determinants of drug-drug interaction associated dispensing in community pharmacies. Drug Saf. 2005; 28(5):371-8. DOI: 10.2165/00002018-200528050-00001. View

13.

Leppin A, Montori V, Gionfriddo M . Minimally Disruptive Medicine: A Pragmatically Comprehensive Model for Delivering Care to Patients with Multiple Chronic Conditions. Healthcare (Basel). 2016; 3(1):50-63. PMC: 4934523. DOI: 10.3390/healthcare3010050. View

14.

Park J, Lee D, Kang H, Kim J, Nahm F, Ahn E . The principles of presenting statistical results using figures. Korean J Anesthesiol. 2022; 75(2):139-150. PMC: 8980283. DOI: 10.4097/kja.21508. View

15.

Gosselin M, Talbot D, Simard M, Chiu Y, Mesidor M, Boiteau V . Classifying Polypharmacy According to Pharmacotherapeutic and Clinical Risks in Older Adults: A Latent Class Analysis in Quebec, Canada. Drugs Aging. 2023; 40(6):573-583. DOI: 10.1007/s40266-023-01028-2. View

16.

Johnell K, Klarin I . The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007; 30(10):911-8. DOI: 10.2165/00002018-200730100-00009. View

17.

Zhan C, Sangl J, Bierman A, Miller M, Friedman B, Wickizer S . Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001; 286(22):2823-9. DOI: 10.1001/jama.286.22.2823. View

18.

Lau S, Waldorff F, Holm A, Frolich A, Andersen J, Sallerup M . Disentangling concepts of inappropriate polypharmacy in old age: a scoping review. BMC Public Health. 2023; 23(1):245. PMC: 9899389. DOI: 10.1186/s12889-023-15013-2. View

19.

Muth C, Blom J, Smith S, Johnell K, Gonzalez-Gonzalez A, Nguyen T . Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus. J Intern Med. 2018; 285(3):272-288. DOI: 10.1111/joim.12842. View

20.

Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K . Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015; 71(12):1415-27. DOI: 10.1007/s00228-015-1954-4. View